Skip to content
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Contact Us
Clinical Evidence
PAD
PAD
DETOUR System
DETOUR System Evidence
DETOUR System Resources
DETOUR System Reimbursement
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Procedural Training
For Patients
About Us
About Us
News
The Team
Careers
External Jobs
Internal Jobs
Contact Us
Search
Read about Endologix
in the news
Embrace the evidence.
The Latest:
Jul 9
Endologix Announces that Scott Huennekens Joins Board of Directors
See Release
All News
Archives
All
2025
2024
2023
2022
2021
Jul 30
Endologix announces first commercial implant of ALTO Abdominal Stent Graft System & official start of U.S. commercial release
May 11
Endologix Announces Completion of Enrollment in the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix EndoVascular Aneurysm Sealing System
Apr 14
Endologix Appoints Tim A. Benner as Chief Commercial Officer
Mar 17
Endologix Adds Jane E. Kiernan to its Board of Directors
Mar 16
Endologix Receives FDA Approval for Alto Abdominal Stent Graft System
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next
